Study: P4P may have little impact on quality

Of late, health plans and employers have been rolling out pay-for-performance programs aggressively on the assumption that such programs offer a helpful method for improving healthcare quality. In fact, more than 150 programs built around rewarding evidence-based care exist, according to research by American Medical News. However, according to one piece of research, some of these efforts might be wasted. That, at least, is the conclusion drawn by a new analysis of quality incentives published in Health Affairs.

The study, which compared 81 Massachusetts physician groups in incentive programs with 73 that were not, found that while overall performance on preventive measures like breast cancer screening and well-child visits improved 73 percent, it was impossible to distinguish one group of physicians from the other statistically. In other words, all physicians' quality improved, whether or not they were jockeying for a bonus.

These results don't necessarily suggest that all P4P programs don't work, the study's authors stressed. The impact of P4P initiatives can vary dramatically depending on how the program is implemented, they noted. Also, American P4P programs tend to offer rewards in the range of 5 percent to 9 percent of payments, which may not be enough to motivate doctors. (In contrast, British doctors can more than double their income by meeting quality targets.)

To learn more about this study:
- read this AMNews piece

Related Articles:
CMS P4P program shows improvements
Top P4P hospitals to score $7M in bonuses from CMS
Calif. group pays out $55M in P4P incentives
Case study: MI groups make P4P dollars through IT use

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.